- Home
- STIM vs SANG Comparison
STIM vs SANG Comparison
Compare STIM & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- SANG
- Stock Information
- Founded
- STIM 2003
- SANG 1984
- Country
- STIM United States
- SANG Canada
- Employees
- STIM N/A
- SANG N/A
- Industry
- STIM Medical/Dental Instruments
- SANG Computer Software: Programming Data Processing
- Sector
- STIM Health Care
- SANG Technology
- Exchange
- STIM Nasdaq
- SANG Nasdaq
- Market Cap
- STIM 192.0M
- SANG 212.3M
- IPO Year
- STIM 2018
- SANG 2021
- Fundamental
- Price
- STIM $4.13
- SANG $5.82
- Analyst Decision
- STIM Buy
- SANG
- Analyst Count
- STIM 4
- SANG 0
- Target Price
- STIM $4.67
- SANG N/A
- AVG Volume (30 Days)
- STIM 2.1M
- SANG 11.7K
- Earning Date
- STIM 03-04-2025
- SANG 02-05-2025
- Dividend Yield
- STIM N/A
- SANG N/A
- EPS Growth
- STIM N/A
- SANG N/A
- EPS
- STIM N/A
- SANG N/A
- Revenue
- STIM $72,711,000.00
- SANG $241,243,000.00
- Revenue This Year
- STIM $3.23
- SANG N/A
- Revenue Next Year
- STIM $29.55
- SANG $3.21
- P/E Ratio
- STIM N/A
- SANG N/A
- Revenue Growth
- STIM 5.03
- SANG N/A
- 52 Week Low
- STIM $0.52
- SANG $3.78
- 52 Week High
- STIM $5.07
- SANG $7.99
- Technical
- Relative Strength Index (RSI)
- STIM 59.06
- SANG 33.78
- Support Level
- STIM $2.80
- SANG $6.17
- Resistance Level
- STIM $5.03
- SANG $6.43
- Average True Range (ATR)
- STIM 0.49
- SANG 0.36
- MACD
- STIM 0.04
- SANG -0.11
- Stochastic Oscillator
- STIM 59.64
- SANG 23.79
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.